Financing roundup: Australian startups collect $ 98 million in the latest financing

Financing roundup: Australian startups collect $ 98 million in the latest financing

Australian startups provided $ 99 million this week in Biotech, AI Healthcare and Quantum Computing.

The largest deal of the week saw the Vaxxas of Queensland a series D-round of $ 49.2 million closing for a rating of $ 805 million, while KwantumSoftWarage company Q-CTRL obtained a defense contract of $ 38 million with the US Department of Defense.

The financing spreads over critical sectors reveals the appetite of investors for Australian Deep Tech Solutions, from needle-free vaccines to AI-driven medical diagnostics and quantum detection technology.

Lucia Bio increases $ 3 million seed extension

Queensland Biotech Lucia Bio supplemented his seed round with an extra $ 2 million, so that the total was collected to $ 3 million. The Uniquest Extension Fund and the use of the exposed managed funds each contributed $ 1 million. The joint venture between the British Molecule for Medicine and Qeddi of the University of Queensland develops Syk inhibitors for autoimmune diseases and neuro inflammation, with Lead activa QED-701 and QED-121.

Steering payments secures $ 5 million Series A

Cross -border payments Fintech send payments $ 5 million collected from existing Backers Regal Funds Management and Kelly+Partners Investment Office, Plus new iPartners from investors. Payments Veteran Matt Barr replaced co -founder Paul Billing as CEO. The platform changes cross -border payments into income flows for Enterprise Partners.

Diag-nose.io and human health receive a government subsidy of $ 3 million

Medical AI Startups Diag-Nose.io and Human Health have provided $ 3 million in federal government financing via the CRC-P program to develop Rhinomap, an AI platform for the treatment of airway disorders, including asthma, sinusitis and COPD. The cooperation relates to findings that up to 50% of serious asthma patients do not achieve expected results.

Vaxxas closes $ 49.2 million series D

Need-free vaccination company Vaxxas closed a series D of $ 49.2 million on a rating of $ 805 million, led by Sprim Global Investments with support from LGT Crestone, Ondeventures and Brandon Capital-Hostplus. The spinout of the University of Queensland has also provided a debt facility of $ 40 million, but has reduced 10% of the staff, moved the founder of David Hoey to strategic adviser and CFO Doug Cubbin became superfluous.

Coursebox picks up $ 750k seed round

Perth Edtech Coursebox collected $ 750k from Purpose Ventures for its AI-driven course creation platform. Founded by Travis Clapp and Alex Hey, the startup has put on more than 180+ countries since mid -2023 more than 180+ countries, with 90% of the turnover of organic traffic.

Q-Ctrl wins $ 38 million defense contract

KwantumSoftWarrebedrijf Q-Ctrl won $ 38 million (US $ 24.4 million) in contracts under the DARPA program of the US Department of Defense, together with Lockheed Martin for Quantum Sensing for military vehicles. The technology treats GPS vulnerability problems with multiple daily flights with malfunctions that cost $ 1B+ daily.

Atlas Consolidated protects USD 18.1m Series B

Atlas Consolidated announced the closure of a USD18.1 million Series B financing round led by Tin Men Capital, with follow-up investments of Strategic Investors Getz, Inc. and Woodside Holdings Investment Management. The HugoHub platform of the company, born in Singapore, enables financial institutions to go beyond Legacy infrastructure and offers more responsive, safe and user-friendly experience for customers in both emerging and developed markets.

Stay informed of our stories LinkedIn” Twitter” Facebook And Instagram.


#Financing #roundup #Australian #startups #collect #million #latest #financing

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *